Table 1.
Quantitative phosphoproteomics in cell lines.
| Study (year) | Biological context | Enrichment method | Quantitation | Identified sites | Ref. |
|---|---|---|---|---|---|
| Olsen et al. (2006) | HeLa cells EGF-stimulated |
TiO2 and SCX | SILAC | 6600 phosphorylation sites on 2244 proteins | [5] |
| Nagaraj et al. (2010) | HeLa | SCX/TiO2 | 9668 phosphorylation sites | [8] | |
| Rigbolt et al. (2011) | Human stem cells | SCX/TiO2 and others | SILAC | 23,522 phosphorylation sites, 6521 proteins | [52] |
| Beli et al. (2012) | Human osteosarcoma cells (U2OS) treated with etoposide or Ionizing radiation | SCX/TiO2 | SILAC | 1470 phosphorylation sites (additionally 1796 lysine acetylation sites) | [74] |
| Mertins et al. (2012) | HeLa cells EGF-stimulated |
SCX/IMAC | iTRAQ & mTRAQ | 12,129 phosphopeptides on 2699 phosphoproteins (iTRAQ); 4448 phosphopeptides on 1597 phosphoproteins | [77] |
| Engholm-Keller (2012) | Rat cell line (INS-1) | ‘TiSH’: TiO2/sequential elution from IMAC/HILIC | 6600 unique phosphopeptides | [35] | |
| Batth et al. (2014) | Mouse 3T3 cells | off-line high-pH chromatography TiO2 | 30,000 unique phosphopeptide variants | [37] | |
| Bennetzen et al. (2010) | GM00130 cells DNA damage-exposed |
ERLIC and TiO2 | SILAC | 5204 phosphorylation sites | [73] |
| Bensimon et al. (2010) | G361 human melanoma cell line DNA damage-exposed |
TiO2 | Label-free | 2871 phosphorylation sites on 1099 proteins | [75] |
| Mertins et al. (2013) | Jurkat cells (human T-cells) | Fe3+-IMAC | 20,800 phosphorylation sites | [35] | |
| Sawney et al. (2013) | Yeast | SCX | Label-free | 2100 phosphorylation cells, 466 proteins | [107] |
| Francavilla et al. (2013) | HeLa cells FGF-stimulated |
Antiphosphotyrosine beads | SILAC | 1212 tyrosine phosphorylated peptides | [71] |
| KumlerI et al. (2014) | Yeast (rapamycin-treated) | SCX/TiO2 | SILAC | 8961 phosphorylation sites, 3590 proteins | [136] |
| de Graaf et al. (2014) | Jurkat cells (human T-cells) | Ti(4+)-IMAC and phosphotyrosine antibody enrichment | Label-free | 16,200 phosphorylation sites | [13] |
| Ruprecht et al. (2015) | Human epidermoid A341 cells | Fe-IMAC in an HPLC format Combined with SCX |
Label-free | 14,00 unique phosphopeptides | [42] |
| Giansanti et al. (2015) | Jurkat T-cells | Ti4+-IMAC | Label-free | 18,430 unique phosphosites | [31] |
Cell studies of phosphoproteomics listing: Biological context of the experiments, Phosphopeptide enrichment method, quantitation method, number of identified sites and reference.
ERLIC: Electrostatic repulsion hydrophilic interaction chromatography; HAMMOC: Hydroxyl acid-modified metal oxide chromatography; iTRAQ: Isobaric tags for relative and absolute quantitation; SCX: Strong cation exchange; TiO2: Titanium dioxide.